Clinical Trials on Canalicular Obstruction

Total 11786 results

Kwong Wah Hospital

Completed

The Effect of High Dose N-acetylcysteine on Airtrapping and Airway Resistance in Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD

China
Novartis Pharmaceuticals

Completed

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

COPD

Spain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
Novartis Pharmaceuticals

Completed

Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

COPD

United States
Hospital de Mataró

Completed

Whole Body Vibration in Chronic Obstructive Pulmonary Disease

COPD

Spain
Novartis

Completed

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States, Argentina, Germany, Spain, Canada, India, Turkey, Sweden, Italy
Revotar Biopharmaceuticals AG

Completed

Study to Evaluate the Effect of Bimosiamose on Ozone Induced Sputum Neutrophilia

Chronic Obstructive Pulmonary Disease (COPD)

Germany
ZonMw: The Netherlands Organisation for Health...
GlaxoSmithKline; Pharmacia; The Netherlands Asthma Foundation

Completed

Smoking Cessation in Patients With COPD (SMOCC) in General Practice (SMOCC)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Phase II Clinical Trial of TQC3721 Suspension for Inhalation

Chronic Obstructive Pulmonary Disease (COPD)

China
University of Parma
Chiesi Farmaceutici S.p.A.

Not yet recruiting

Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE) (EFFICACE)

COPD, Chronic Obstructive Pulmonary Disease

Italy
Imperial College London
National Institute for Health Research, United Kingdom

Completed

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

ASTHMA | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | HEALTHY SUBJECTS

United Kingdom
University Hospital, Ghent

Completed

Autonomic Function in Patients With COPD

Autonomic Function in Patients With Chronic Obstructive Pulmonary Disease

Belgium
Shanghai Zhongshan Hospital
Ruijin Hospital; The First Affiliated Hospital of Guangzhou Medical University

Completed

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract (PAEAN)

Chronic Obstructive Pulmonary Disease (COPD)

China
AstraZeneca

Completed

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Nephron Pharmaceuticals Corporation
Rho, Inc.

Completed

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Augusta University

Completed

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease (COPD-LT)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Turino, Gerard, M.D.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Zurich

Completed

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Exercise Performance

Chronic Obstructive Pulmonary Disease (COPD)

Switzerland
Sunovion

Terminated

A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Zurich
National Center of Cardiology and Internal Medicine named after academician...

Completed

Altitude Related Illness In Patients With Respiratory Disease

Chronic Obstructive Pulmonary Disease (COPD)

Kyrgyzstan
AstraZeneca

Completed

Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination

Chronic Obstructive Pulmonary Disease (COPD)

Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Sweden, Ukraine, United Kingdom
AstraZeneca

Completed

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Southeast University, China

Completed

Is it Necessary to Set External PEEP in AECOPD Patients

Acute Exacerbation Chronic Obstructive Pulmonary Disease

China
Novartis Pharmaceuticals

Completed

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD) (QUANTIFY)

Chronic Obstructive Pulmonary Disease (COPD)

Germany
AstraZeneca

Completed

The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Poland
Odense University Hospital
Region of Southern Denmark

Completed

Early Telemedicine Training in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
AstraZeneca

Completed

Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

Chronic Obstructive Pulmonary Disease, COPD

Sweden, France, Germany, Hungary, Poland, Canada, Australia, Slovakia, Spain
Emphycorp
Cellular Sciences, inc.

Completed

Sodium Pyruvate Therapy in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Huashan Hospital

Unknown

Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD (REASON)

Microbiome | Acute Exacerbation of Chronic Obstructive Pulmonary Disease

China
National Taiwan University Hospital

Completed

DU and BOO in Women With and Without Symptoms of VD

Bladder Outlet Obstruction | Detrusor Underactivity

Taiwan
Nanfang Hospital of Southern Medical University
Boston Scientific Corporation

Unknown

Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction

Colorectal Cancer | Colonic Obstruction | Acute Malignant Colonic Obstruction

China
AstraZeneca
Parexel

Completed

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients (TRIBUTE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pearl Therapeutics, Inc.

Completed

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

COPD

United States
Guangzhou Institute of Respiratory Disease

Completed

Quality Control for Chronic Obstructive Pulmonary Disease

COPD

China
Bayside Health
Newcastle University; Austin Health

Completed

Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease

COPD

Australia
Fisher and Paykel Healthcare
Medical Research Institute of New Zealand; Alana Healthcare

Terminated

Nasal High Flow Therapy 30 Day Readmission Study (N3ADS)

Chronic Obstructive Pulmonary Disease | COPD

United States, New Zealand
Chiesi Farmaceutici S.p.A.

Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD (GlycoNEXT)

Chronic Obstructive Pulmonary Disease (COPD)

Czechia, Germany, Hungary, Romania
Cardiff University
GlaxoSmithKline; Cardiff Metropolitan University

Completed

Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

Phase IV O2 Consumption Study in COPD Patients.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
Assiut University

Unknown

VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients

COPD

Egypt
Radboud University Medical Center

Unknown

Exacerbation Self-management in COPD: The ACCESS Study (ACCESS)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
Brigham and Women's Hospital
AstraZeneca

Terminated

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo (AZCO)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pearl Therapeutics, Inc.

Completed

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Aarhus
Aarhus University Hospital

Completed

Magnesium is Associated With QoL in COPD: A Cross-sectional Study

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Universidad de Granada

Completed

Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease

COPD

Spain
Medical University of Warsaw

Unknown

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

COPD

Poland
University Hospital Southampton NHS Foundation...
GlaxoSmithKline

Completed

Microbiology & Immunology of the Chronically-inflamed Airway (MICA)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Novartis Pharmaceuticals

Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico

Clinical Trials on Canalicular Obstruction

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations